The social brain network and autism

Vivek Misra, Vivek Misra

Abstract

Available research data in Autism suggests the role of a network of brain areas, often known as the 'social brain'. Recent studies highlight the role of genetic mutations as underlying patho-mechanism in Autism. This mini review, discusses the basic concepts behind social brain networks, theory of mind and genetic factors associated with Autism. It critically evaluates and explores the relationship between the behavioral outcomes and genetic factors providing a conceptual framework for understanding of autism.

Keywords: Autism; Behavioral Genetics; Brain Networks.

Figures

Fig. 1:
Fig. 1:
Proteins with genetic variants associated with autism spectrum disorder (ASD) (excluding those in white ovals) are clustered in specific intracellular processes. In colour, proteins with genetic variants associated with ASD; in white, proteins not directly associated with ASD. From Ghosh et al., Nat Rev Drug Discov. 2013;12(10):777-90. Reprinted with permission.

References

    1. Hutsler J, Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain research. 2010;1309:83–94.
    1. Casanova M, Buxhoeveden D, Switala A et al. Neuronal density and architecture (Gray Level Index) in the brains of autistic patients. Journal of child neurology. 2002;17(7):515–21.
    1. Schultz R. Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. International journal of developmental neuroscience: the official journal of the International Society for Developmental Neuroscience. 2005;23(2–3):125–41.
    1. Grelotti D, Klin A, Gauthier I et al. fMRI activation of the fusiform gyrus and amygdala to cartoon characters but not to faces in a boy with autism. Neuropsychologia. 2005;43(3):373–85.
    1. Pelphrey K, Morris J, McCarthy G. Neural basis of eye gaze processing deficits in autism. Brain: a journal of neurology. 2005;128(Pt 5):1038–48.
    1. Frith U, Morton J, Leslie A. The cognitive basis of a biological disorder: autism. Trends in neurosciences. 1991;14(10):433–8.
    1. Brambilla P, Hardan A, di Nemi S et al. The functional neuroanatomy of autism. Functional neurology. 2004;19(1):9–17.
    1. Castelli F, Frith C, Happé F et al. Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain: a journal of neurology. 2002;125(Pt 8):1839–49.
    1. Cattaneo L, Rizzolatti G. The mirror neuron system. Archives of neurology. 2009;66(5):557–60.
    1. Iacoboni M, Dapretto M. The mirror neuron system and the consequences of its dysfunction. Nature reviews Neuroscience. 2006;7(12):942–51.
    1. Hamilton A, Brindley R, Frith U. Imitation and action understanding in autistic spectrum disorders: how valid is the hypothesis of a deficit in the mirror neuron system? Neuropsychologia. 2007;45(8):1859–68.
    1. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain research. 2011;1380:42–77.
    1. Eapen V. Genetic basis of autism: is there a way forward? Current opinion in psychiatry. 2011;24(3):226–36.
    1. O’Roak BJ, Vives L, Girirajan S et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485(7397):246–50.
    1. Bi C, Wu J, Jiang T et al. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility. Human mutation. 2012;33(12):1635–8.
    1. Bill BR, Geschwind DH. Genetic advances in autism: heterogeneity and convergence on shared pathways. Current opinion in genetics & development. 2009;19(3):271–8.
    1. Glessner JT, Wang K, Cai G et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459(7246):569–73.
    1. Feng J, Schroer R, Yan J et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neuroscience letters. 2006;409(1):10–3.
    1. Chen X, Shen Y, Zhang F et al. Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs. American journal of human genetics. 2013;92(3):375–86.
    1. Wis´niowiecka-Kowalnik B, Nesteruk M, Peters SU et al. Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2010;153B(5):983–93.
    1. O’Roak BJ, Vives L, Fu W et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science (New York, NY) 2012;338(6114):1619–22.
    1. Sanders SJ, Murtha MT, Gupta AR et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature. 2012;485(7397):237–41.
    1. Neale BM, Kou Y, Liu L et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485(7397):242–5.
    1. O’Roak BJ, Deriziotis P, Lee C et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature genetics. 2011;43(6):585–9.
    1. Miles JH. Autism spectrum disorders-a genetics review. Genetics in medicine: official journal of the American College of Medical Genetics. 2011;13(4):278–94.
    1. Wang K, Zhang H, Ma D et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature. 2009;459(7246):528–33.
    1. Pinto D, Pagnamenta AT, Klei L et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010;466(7304):368–72.
    1. Schaefer GB, Mendelsohn NJ, Professional P et al. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genetics in medicine: official journal of the American College of Medical Genetics. 2013;15(5):399–407.
    1. Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature. 2013;493(7432):327–37.
    1. Varga EA, Pastore M, Prior T et al. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genetics in medicine: official journal of the American College of Medical Genetics. 2009;11(2):111–7.
    1. Santini E, Huynh TN, MacAskill AF et al. Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature. 2013;493(7432):411–5.
    1. Carter MT, Scherer SW. Autism spectrum disorder in the genetics clinic: a review. Clinical genetics. 2013;83(5):399–407.
    1. Scherer SW, Dawson G. Risk factors for autism: translating genomic discoveries into diagnostics. Human genetics. 2011;130(1):123–48.
    1. Berkel S, Marshall CR, Weiss B et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nature genetics. 2010;42(6):489–91.
    1. van Bon BW, Hoischen A, Hehir-Kwa J et al. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clinical genetics. 2011;79(3):296–9.
    1. Durand CM, Betancur C, Boeckers TM et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature genetics. 2007;39(1):25–7.
    1. Moessner R, Marshall CR, Sutcliffe JS et al. Contribution of SHANK3 mutations to autism spectrum disorder. American journal of human genetics. 2007;81(6):1289–97.
    1. Boeckers TM, Bockmann J, Kreutz MR et al. ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. Journal of neurochemistry. 2002;81(5):903–10.
    1. Noor A, Whibley A, Marshall CR et al. Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Science translational medicine. 2010;2(49)
    1. Jamain S, Quach H, Betancur C et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature genetics. 2003;34(1):27–9.
    1. Laumonnier F, Bonnet-Brilhault F, Gomot M et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. American journal of human genetics. 2004;74(3):552–7.
    1. Daoud H, Bonnet-Brilhault F, Védrine S et al. Autism and nonsyndromic mental retardation associated with a de novo mutation in the NLGN4X gene promoter causing an increased expression level. Biological psychiatry. 2009;66(10):906–10.
    1. Nava C, Lamari F, Héron D et al. Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Translational psychiatry. 2012:2.
    1. Celestino-Soper PB, Violante S, Crawford EL et al. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(21):7974–81.
    1. Doll C, Broadie K. Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models. Frontiers in cellular neuroscience. 2014;8:30.
    1. Ghosh A, Michalon A, Lindemann L, Fontoura P, Santarelli L. Drug discovery for autism spectrum disorder: challenges and opportunities. Nature reviews Drug discovery. 2013;12(10):777–90.
    1. Sigurdsson T, Stark K, Karayiorgou M et al. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature. 2010;464(7289):763–7.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere